Kanabo Group Plc (LON:KNB)
London · Delayed Price · Currency is GBP · Price in GBX 0.2250
-0.0750 (-25.00%)
Apr 30, 2025, 4:20 PM BST
Verve Therapeutics Market Cap
Kanabo Group has a market cap or net worth of 1.42 million as of August 1, 2025. Its market cap has decreased by -86.76% in one year.
Market Cap
1.42M
Enterprise Value
-472.04K
Revenue
1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
Market Cap Chart
Since February 17, 2021, Kanabo Group's market cap has decreased from 146.97M to 1.42M, a decrease of -99.03%. That is a compound annual growth rate of -66.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 1.42M | -73.53% |
| Dec 31, 2024 | 5.38M | -69.64% |
| Dec 29, 2023 | 17.71M | 120.37% |
| Dec 30, 2022 | 8.04M | -84.49% |
| Dec 31, 2021 | 51.80M | -64.76% |
| Feb 17, 2021 | 146.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 173.02B |
| GSK plc | 56.40B |
| Haleon | 32.99B |
| Smith & Nephew | 10.33B |
| ConvaTec Group | 5.00B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 2.45B |
| Oxford Nanopore Technologies | 1.97B |